Capula Management »

Verve Therapeutics shares owned by Capula Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Capula Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $634k 46k 13.94

More positions owned by Capula Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vaneck Etf Trust Semiconductr Etf (SMH)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A (META)
Amazon Put Option (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Pioneer Natural Resources (PXD)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Spdr Ser Tr S&p Regl Bkg Call Option (KRE)
Ishares Tr Msci Emg Mkt Etf (EEM)
Select Sector Spdr Tr Financial (XLF)
Capri Holdings SHS (CPRI)

View all positions for Capula Management

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics